Presidential Budget Request Jeopardizes NIH Funding for PD Research 

Posted on by APDA

Presidential Budget Request Jeopardizes NIH Funding for Parkinson’s Research  President Trump’s FY 2027 (October 1, 2026-September 30, 2027) budget request, released on April...see more 3, includes a 20% cut to the National Institutes of Health (NIH). The proposed cuts jeopardize efforts to increase NIH funding for Parkinson’s disease (PD) research. The American Parkinson Disease Association (APDA), in unison with the Michael J. Fox Foundation and the Parkinson’s Foundation, […]

Read More

Carbidopa/Levodopa and its relationship to Vitamin B6 and Vitamin B12

Posted on by APDA

People with Parkinson’s disease (PD) often hear about how protein can interfere with carbidopa/levodopa, but fewer realize that it...see more is also important to pay attention to Vitamin B6 and B12. Carbidopa/levodopa can interfere with Vitamin B6 and Vitamin B12 processing, causing deficiencies in these vitamins. Low levels of Vitamin B6 and B12 can cause or […]

Read More

Japan Approves First Stem-Cell Therapy for Parkinson’s Disease

Posted on by APDA

A major milestone has been reached as Japan has approved the world’s first stem-cell-based therapy for Parkinson’s disease (PD)....see more The innovation was developed by Sumitomo Pharma in collaboration with Dr. Jun Takahashi at Kyoto University. This treatment represents a new approach that could potentially restore lost brain cells of PD. How it Works Dr. Takahashi […]

Read More

Parkinson’s Perspectives: Living with Young Onset Parkinson’s

Posted on by APDA

We spoke with three people who are living with young onset Parkinson’s disease (YOPD), also called early onset PD,...see more which describes diagnoses received before age 50. Each interviewee brings a distinct perspective on navigating PD at an earlier stage of life, sharing the unique challenges they’ve faced, the unexpected ways PD has reshaped their identities, the […]

Read More

Bipartisan HEALTHY BRAINS Act Introduced to Combat Rising Neurodegenerative Disease Crisis

Posted on by APDA

APDA’s Public Policy & Advocacy team was on hand yesterday as lawmakers unveiled the Harmonizing Environmental Analyses and Launching...see more Therapeutic Hubs to Yield Bolstered Research and Innovation in Neurological Science (HEALTHY BRAINS) Act (H.R. 7779.) Introduced by Representative Gus Bilirakis (R-FL) and Representative Suhas Subramanyam (D-VA), the sweeping bipartisan initiative is aimed at strengthening federal […]

Read More

Syngenta to Cease Paraquat Production, Fight for Full Ban Must Continue 

Posted on by APDA

Syngenta to Cease Paraquat Production, Fight for Full Ban Must Continue  In a significant development for the agricultural and public health...see more communities, Syngenta announced that in June 2026 it will stop producing paraquat, a widely used and highly toxic herbicide that has been linked in multiple scientific studies to an increased risk of Parkinson’s disease (PD).  Anne Hubbard, APDA’s Chief Public […]

Read More